AusPAR: Tildrakizumab

Australian Public Assessment Report

AusPAR

AusPAR: Tildrakizumab [PDF, 1.36 MB]

AusPAR: Tildrakizumab [Word, 4.75 MB]

Attachment: Product Information: Tildrakizumab [PDF, 335.54 KB]

Attachment: Product Information: Tildrakizumab [Word, 630.32 KB]

Device/Product Name

Ilumya

Active ingredients

Tildrakizumab

AusPAR Date

24 September 2019

Published

4 October 2019

Submission Number

PM-2017-02274-1-1

Submission Type

New biological entity

Decision

Approved